RxDoctor Payments Data

Cynthia Daniel, PA

Physician Assistant · Corbin, KYNPI 1831143833

Payments from drug & device makers

$3,092in general payments, 2019–2025

Across 177 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$685
  • Lundbeck LLC$469
  • Alkermes, Inc.$450
  • Johnson & Johnson$354
  • Neurocrine Biosciences, Inc.$282
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$225
  • plus $627 from 6 others

What the payments were for

  • Food & beverage$2,95696%
  • Education$1364%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,092 in reported general payments places this provider in the 85th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$8,856
Medicare patients
25
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate49$412,398
VraylarCariprazine Hcl66$94,164
Invega SustennaPaliperidone Palmitate26$88,684
RexultiBrexpiprazole54$78,631
LybalviOlanzapine/Samidorphan Malate12$19,065
SaphrisAsenapine Maleate13$17,801
TrintellixVortioxetine Hydrobromide23$10,873
Paliperidone ErPaliperidone26$7,865
Quetiapine Fumarate222$4,140
Chlorpromazine Hcl16$3,223
Olanzapine116$2,253
Ziprasidone Hcl42$2,146
Divalproex Sodium ErDivalproex Sodium61$1,731
Fluvoxamine Maleate19$1,722
Aripiprazole50$1,427

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$282$412,39849 claims
AbbVieVraylar, Saphris$184$111,96679 claims
Johnson & JohnsonInvega Sustenna$354$88,68426 claims
Otsuka America Pharmaceutical, Inc.Rexulti$685$78,63154 claims
Alkermes, Inc.Lybalvi$450$19,06512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →